📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
17
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split
55%
• 50-day avg $0.01 below $1 exchange minimum
💹 Market Data
Market Cap$10.78M
Shares Outstanding890.74M
Float688.85M
Cash$408.0K
Debt$985.0K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest89.4K
Days to Cover1.0
% of Float0.0%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 29, 2025
8-K
8K EVENT
Feb 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for APYP
📊 APYP FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 APYP Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.